Clinical Trial Update: Clonidine to Prevent Delirium After Electroconvulsive Therapy. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating clonidine to prevent delirium after electroconvulsive therapy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Catatonia
• Delirium
• Major Depressive Disorder

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Major Depressive Disorder, Catatonia | Phase 4 | Status: RECRUITING